**Question:** The drug approved for obesity treatment along with Phentermine is

A. Qsymia (Vyvanse)
B. Contrave
C. Alli
D. Saxenda

**Correct Answer:** B. Contrave

**Core Concept:**
Obesity is a complex condition characterized by excessive body fat accumulation, which can lead to various health complications. Combination therapy using two or more agents targeting different aspects of obesity management is often employed to enhance treatment outcomes. In this context, Phentermine is a sympathomimetic amine that acts as a central nervous system stimulant, reducing appetite, and improving energy expenditure. These medications are often used in combination to maximize therapeutic effects while minimizing potential side effects.

**Why the Correct Answer is Right:** Contrave (Bupropion and Naltrexone) is a combination therapy specifically approved for the treatment of obesity. Bupropion is an antidepressant that inhibits dopamine and norepinephrine reuptake, leading to increased dopamine release in the hypothalamus, which suppresses appetite. Naltrexone is an opioid receptor antagonist that reduces food intake by counteracting the reinforcing properties of opioids, thus preventing overeating.

**Why Each Wrong Option is Incorrect:**

A. Qsymia (Vyvanse): While Vyvanse is a central nervous system stimulant like Phentermine, it primarily targets attention deficit hyperactivity disorder (ADHD) rather than obesity. Vyvanse is a lysergic acid diethylamide (LSD)-like psychoactive drug that inhibits dopamine, norepinephrine, and serotonin reuptake, leading to increased neurotransmitter levels in the brain. This effect is not specific to obesity treatment and may have additional side effects compared to Contrave.

B. Contrave (Bupropion and Naltrexone) is the correct answer, as explained above.

C. Alli (Orlistat): Orlistat is a lipase inhibitor that blocks the absorption of dietary fats in the intestine, reducing caloric intake. Although effective in reducing body weight, it is not combined with a central nervous system stimulant like Phentermine or Contrave.

D. Saxenda (Liraglutide): Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that stimulates satiety and reduces food intake. While effective in weight loss, it does not combine with a central stimulant like Contrave.

**Clinical Pearls:**

1. **Naltrexone**: It is an opioid receptor antagonist that reduces food intake and cravings by blocking the effects of opioids in the brain. When combined with Bupropion, the effect is synergistic, meaning that the combined action of the two drugs is greater than the sum of their individual effects. This synergistic interaction is crucial for the success of Contrave in weight loss treatment.
2. **Bupropion**: It is an antidepressant that primarily targets dopamine and norepinephrine reupt